<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7090771\results\search\testTrace\results.xml">
  <result pre="Review Article Diagnosis, treatment, and prevention of 2019 novel coronavirus" exact="infection" post="in children: expertsâ€™ consensus statement ShenKunlingkunlingshen1717@163.com1YangYonghongyyh628628@sina.com2WangTianyou3ZhaoDongchizhao_wh2004@hotmail.com4JiangYi5JinRunming6ZhengYuejie7XuBaoping1XieZhengde2LinLikai8ShangYunxiao9LuXiaoxia10ShuSainan11BaiYan6DengJikui12LuMin13YeLeping14WangXuefeng15WangYongyan16GaoLiwei1collab: China National Clinical"/>
  <result pre="global pandemic. Abstract Since the outbreak of 2019 novel coronavirus" exact="infection" post="(2019-nCoV) in Wuhan City, China, by January 30, 2020,"/>
  <result pre="Standards (the fourth edition) (National Health Committee) and other previous" exact="diagnosis" post="and treatment strategies for pediatric virus infections. The present"/>
  <result pre="fourth edition) (National Health Committee) and other previous diagnosis and" exact="treatment" post="strategies for pediatric virus infections. The present consensus statement"/>
  <result pre="summarizes current strategies on diagnosis, treatment, and prevention of 2019-nCoV" exact="infection" post="in children. Background In December, 2019, a cluster of"/>
  <result pre="exact origin remains unclear. 2019-nCoV infected patients are the main" exact="infection" post="sources. However, we also should attach importance to asymptomatic"/>
  <result pre="Close contact with symptomatic cases and asymptomatic cases with silent" exact="infection" post="are the main transmission routes of 2019-nCoV infection in"/>
  <result pre="with silent infection are the main transmission routes of 2019-nCoV" exact="infection" post="in children. People of all ages are susceptible to"/>
  <result pre="severe cases. Thus far, all pediatric cases with laboratory-confirmed 2019-nCoV" exact="infection" post="were mild cases, andÂ no deaths hadÂ been reported."/>
  <result pre="Standards (the fourth edition) (National Health Committee) and other previous" exact="diagnosis" post="and treatment strategies for pediatric virus infections. Clinical manifestations"/>
  <result pre="fourth edition) (National Health Committee) and other previous diagnosis and" exact="treatment" post="strategies for pediatric virus infections. Clinical manifestations Based on"/>
  <result pre="is highly homologous with the known 2019-nCoV. Clinical classifications Asymptomatic" exact="infection" post="(silent infection) Children tested positive for 2019-nCoV, but without"/>
  <result pre="symptoms or abnormal chest imaging findings. Acute upper respiratory tract" exact="infection" post="Children with only fever, cough, pharyngeal pain, nasal congestion,"/>
  <result pre="Early identification of critical cases According to the experiences in" exact="diagnosis" post="and treatment of community-acquired pneumonia in children, children with"/>
  <result pre="of critical cases According to the experiences in diagnosis and" exact="treatment" post="of community-acquired pneumonia in children, children with a history"/>
  <result pre="months; Extrapulmonary complications; Coinfection with other viruses and/or bacteria. Differential" exact="diagnosis" post="[3] Differential diagnosis should be made to distinguish from"/>
  <result pre="Coinfection with other viruses and/or bacteria. Differential diagnosis [3] Differential" exact="diagnosis" post="should be made to distinguish from influenza virus, parainfluenza"/>
  <result pre="should be admitted to ICU as soon as possible. General" exact="treatment" post="The general treatment strategies include bed rest and supportive"/>
  <result pre="to ICU as soon as possible. General treatment The general" exact="treatment" post="strategies include bed rest and supportive treatment; ensuring sufficient"/>
  <result pre="re-examination of chest imaging should be performed when necessary. Symptomatic" exact="treatment" post="The patients with high fever should be actively controlled."/>
  <result pre="water bath, use of antipyretic patch, etc.) or antipyretic drug" exact="treatment" post="should be performed. Common drugs include: ibuprofen orally, 5â€&quot;10Â"/>
  <result pre="Interferon-Î± can reduce viral load in the early stage of" exact="infection" post="which can help to alleviate symptoms and shorten the"/>
  <result pre="29, 30] Lopinavir/litonavir has been tried to apply to the" exact="treatment" post="of adult patients with 2019-nCoV pneumonia, but its efficacy"/>
  <result pre="Different regions can refer to the following plans for dialectical" exact="treatment" post="according to the patientâ€™s conditions, local climate features, and"/>
  <result pre="conditions, local climate features, and physical characteristics of children. Clinical" exact="treatment" post="period Asymptomatic infection: Therapeutic methods: strengthening the healthy and"/>
  <result pre="Sharen (Fructus amomi) (to be added in later). Psychotherapy Psychological" exact="counseling" post="plays an important role in disease recovery. If patients"/>
  <result pre="mood swing, fear, or psychological disorders, active psychological intervention and" exact="treatment" post="are needed. Release and discharge criteria [3] Confirmed patients"/>
  <result pre="and discharge criteria [3] Confirmed patients can be discharged from" exact="isolation" post="or transferred to the corresponding departments for treatment of"/>
  <result pre="discharged from isolation or transferred to the corresponding departments for" exact="treatment" post="of other diseases if all the following criteria are"/>
  <result pre="longer than 3Â days; The respiratory symptoms improve obviously; The" exact="detection" post="of respiratory pathogenic nucleic acid is negative for two"/>
  <result pre="at least 1Â day). Suspected patients can be discharged from" exact="isolation" post="when the detection of respiratory pathogenic nucleic acid is"/>
  <result pre="day). Suspected patients can be discharged from isolation when the" exact="detection" post="of respiratory pathogenic nucleic acid is negative for two"/>
  <result pre="interval is at least 1Â day). Prevention [33â€&quot;35] Novel coronavirus" exact="infection" post="is a new communicable disease with an emergent outbreak"/>
  <result pre="disease with an emergent outbreak that affects all populations. 2019-nCoV" exact="infection" post="has been classified as category B infectious disease legally"/>
  <result pre="as category A infectious disease. It is paramount to implement" exact="infection" post="control practices by infection source controlling, transmission route blocking,"/>
  <result pre="disease. It is paramount to implement infection control practices by" exact="infection" post="source controlling, transmission route blocking, and susceptible population protection."/>
  <result pre="source controlling, transmission route blocking, and susceptible population protection. Controlling" exact="infection" post="sources Patients infected with 2019-nCoV are the main infection"/>
  <result pre="Controlling infection sources Patients infected with 2019-nCoV are the main" exact="infection" post="sources. Children infected by novel coronavirus should be isolated"/>
  <result pre="3.National Health Commission of Peopleâ€™s Republic of China. Diagnosis and" exact="treatment" post="of pneumonia caused by novel coronavirus (trial version 4)."/>
  <result pre="Medical Associationcollab: Hubei Pediatric Medical Quality Control CenterSuggestions on the" exact="diagnosis" post="and treatment of novel coronavirus infection in children in"/>
  <result pre="Hubei Pediatric Medical Quality Control CenterSuggestions on the diagnosis and" exact="treatment" post="of novel coronavirus infection in children in Hubei province"/>
  <result pre="Control CenterSuggestions on the diagnosis and treatment of novel coronavirus" exact="infection" post="in children in Hubei province (trial version 1)CJCP.202022969932051073 5.ChanJFYuanSKokKHWangKKChuHYangJet"/>
  <result pre="Health Commission of People's Republic of China. Code for the" exact="diagnosis" post="and treatment of community-acquired pneumonia in children (2019 edition)."/>
  <result pre="of People's Republic of China. Code for the diagnosis and" exact="treatment" post="of community-acquired pneumonia in children (2019 edition). https://www.nhc.gov.cn/yzygj/s7653/201902/bfa758ad6add48a599bc74b588a6e89a.shtml. Access"/>
  <result pre="19.HijanoDRSiefkerDTShresthaBJaligamaSType I interferon potentiates IgA immunity to respiratory syncytial virus" exact="infection" post="during infancySci Rep201881103410.1038/s41598-018-29456-w30038294 20.ShenKLShangYXZhangGCXuBPFuZCaoLet al.Expert consensus on rational application"/>
  <result pre="Health Commission of People's Republic of China. Guidelines on the" exact="diagnosis" post="and treatment of hand, foot and mouth disease (2018"/>
  <result pre="of People's Republic of China. Guidelines on the diagnosis and" exact="treatment" post="of hand, foot and mouth disease (2018 edition). https://www.nhc.gov.cn/yzygj/s3594q/201805/5db274d8697a41ea84e88eedd8bf8f63.shtml."/>
  <result pre="and safety of recombinant human interferon Î±2b spray in the" exact="treatment" post="of hand, foot and mouth disease in childrenChin J"/>
  <result pre="Center for Medical Quality Control of Infectious DiseasesExpert consensus on" exact="diagnosis" post="and treatment of herpetic pharyngitis (2019 edition)Chin J Pediatr.201957177180"/>
  <result pre="Medical Quality Control of Infectious DiseasesExpert consensus on diagnosis and" exact="treatment" post="of herpetic pharyngitis (2019 edition)Chin J Pediatr.201957177180 26.ShenKLShangYXZhangHA multicenter,"/>
  <result pre="safety of recombinant human interferon 2b spray (pseudomonas) in the" exact="treatment" post="of acute upper respiratory tract infection in childrenChin J"/>
  <result pre="spray (pseudomonas) in the treatment of acute upper respiratory tract" exact="infection" post="in childrenChin J Appl Clin Pediatr20193410101016 27.GaoHZhangLLWeiQDuanZJTuXMYuZAet al.Preventive and"/>
  <result pre="therapeutic effects of recombinant IFN -Î±2b nasal spray on SARS-CoV" exact="infection" post="in Macaca mulataChin J Exp Clin Virol200519207211 28.YuDXChenQZhangLLLiuYYuZALiZFet al.A"/>
  <result pre="infectionsChin J Exp Clin Virol200519216219 29.ChuCMRole of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findingsThorax20045925225610.1136/thorax.2003.01265814985565 30.AbbVie Deutschland"/>
  <result pre="PLA200420274276 32.National Health Commission of People's Republic of China. Influenza" exact="diagnosis" post="and treatment protocol (revised edition 2019). https://wenku.baidu.com/view/00f0d41d2079168884868762caaedd3383c4b57f.html. Access 30"/>
  <result pre="Health Commission of People's Republic of China. Influenza diagnosis and" exact="treatment" post="protocol (revised edition 2019). https://wenku.baidu.com/view/00f0d41d2079168884868762caaedd3383c4b57f.html. Access 30 Nov 2019."/>
  <result pre="Organization. Home care for patients with suspected novel coronavirus (nCoV)" exact="infection" post="presenting with mild symptoms and management of contacts. https://www.who.int/internal-publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(nCoV)-infection-presenting-with-mild-symptoms-and-management-of-contacts."/>
 </snippets>
</snippetsTree>
